These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7847836)

  • 1. Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.
    Barbieri F; Parodi G; Massa T; Cagnoli M; Barbi G; Imperiale A; Alama A
    Anticancer Res; 1994; 14(5A):1973-7. PubMed ID: 7847836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single cell multiple biomarker analysis in archival breast fine-needle aspiration specimens: quantitative fluorescence image analysis of DNA content, p53, and G-actin as breast cancer biomarkers.
    Rao JY; Apple SK; Hemstreet GP; Jin Y; Nieberg RK
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1027-33. PubMed ID: 9829712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
    Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
    Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast carcinomas with immunocytochemical detection of aromatase in fine-needle aspirates: report of three cases.
    Tsunoda Y; Shimizu Y; Tsunoda A; Kamiya K; Kusano M; Takimoto M
    Hum Pathol; 2001 Mar; 32(3):348-51. PubMed ID: 11274648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specimen adequacy and false-negative diagnosis rate in fine-needle aspirates of palpable breast masses.
    Boerner S; Sneige N
    Cancer; 1998 Dec; 84(6):344-8. PubMed ID: 9915135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
    Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
    Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.
    Ernst LM; Rimm DL
    Cancer; 2002 Oct; 96(5):275-9. PubMed ID: 12378594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fine needle aspiration and Tru-Cut biopsy of palpable mammary lesions.
    Scopa CD; Koukouras D; Spiliotis J; Harkoftakis J; Koureleas S; Kyriakopoulou D; Tzoracoleftherakis E
    Cancer Detect Prev; 1996; 20(6):620-4. PubMed ID: 8939348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
    Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
    Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative polymerase chain reaction analysis of c-myc amplification on archival breast fine-needle aspiration materials.
    Rao JY; Apple SK; Jin Y; Lin S; Nieberg RK; Hirtschowitz SL
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):175-9. PubMed ID: 10698478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
    Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
    Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical implications of telomerase activity in breast cancer fine-needle aspirates].
    Jin S; Zhang W; Teng M
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):132-4. PubMed ID: 11776640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
    Hiyama E; Saeki T; Hiyama K; Takashima S; Shay JW; Matsuura Y; Yokoyama T
    Cancer; 2000 Aug; 90(4):235-8. PubMed ID: 10966564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
    Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
    Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of core-needle biopsy vs fine-needle aspiration on pathologic measurement of tumor size in breast cancer.
    Yang JH; Lee WS; Kim SW; Woo SU; Kim JH; Nam SJ
    Arch Surg; 2005 Feb; 140(2):125-8. PubMed ID: 15723992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeterminate breast fine-needle aspiration: repeat aspiration or core needle biopsy?
    Kooistra B; Wauters C; Strobbe L
    Ann Surg Oncol; 2009 Feb; 16(2):281-4. PubMed ID: 19050965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary staging by percutaneous biopsy: sensitivity of fine-needle aspiration versus core needle biopsy.
    Rao R; Lilley L; Andrews V; Radford L; Ulissey M
    Ann Surg Oncol; 2009 May; 16(5):1170-5. PubMed ID: 19263171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative axillary staging in breast cancer-saving time and resources.
    Tahir M; Osman KA; Shabbir J; Rogers C; Suarez R; Reynolds T; Bucknall T
    Breast J; 2008; 14(4):369-71. PubMed ID: 18540958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses.
    Assersohn L; Gangi L; Zhao Y; Dowsett M; Simon R; Powles TJ; Liu ET
    Clin Cancer Res; 2002 Mar; 8(3):794-801. PubMed ID: 11895911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue aspiration cytopathology.
    Wakely PE; Kneisl JS
    Cancer; 2000 Oct; 90(5):292-8. PubMed ID: 11038426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.